1933 Industries - neue Chance??? (Seite 344)
eröffnet am 26.06.17 10:51:37 von
neuester Beitrag 29.04.24 09:40:37 von
neuester Beitrag 29.04.24 09:40:37 von
Beiträge: 8.912
ID: 1.256.039
ID: 1.256.039
Aufrufe heute: 2
Gesamt: 770.233
Gesamt: 770.233
Aktive User: 0
ISIN: CA65442F1053 · WKN: A2N61A · Symbol: TGIF
0,0107
USD
+1,43 %
+0,0002 USD
Letzter Kurs 17.05.24 Nasdaq OTC
Neuigkeiten
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,8000 | +45,45 | |
| 1,0000 | +42,86 | |
| 3,0000 | +42,18 | |
| 6,2500 | +24,75 | |
| 0,9600 | +18,93 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,9300 | -17,52 | |
| 23,700 | -19,52 | |
| 28,60 | -24,06 | |
| 1,3500 | -25,62 | |
| 0,7800 | -29,73 |
Beitrag zu dieser Diskussion schreiben
Feedback
In Q4, Infused reports $1,546,508 in sales revenues, an increase of 30% from $1,192,051 in Q3 from its hemp-based, CBD-infused wellness product lines.
Alternative Medicine Association reports $2,282,485 in sales revenue in Q4, up 9% from $2,102,453 in Q3, driven by strong sales of cannabis flower and concentrates.
Von AMA hätte ich mir etwas mehr erhofft. Aber Infused sehr stark.
Alternative Medicine Association reports $2,282,485 in sales revenue in Q4, up 9% from $2,102,453 in Q3, driven by strong sales of cannabis flower and concentrates.
Von AMA hätte ich mir etwas mehr erhofft. Aber Infused sehr stark.
Bin gespannt ob sich die Zahlen auch mal auf den Kurs auswirken und wir mal wieder die 0,40usd sehen.
Antwort auf Beitrag Nr.: 59.322.167 von kwhistler am 29.11.18 00:28:30https://mailchi.mp/fridaynightinc.com/1933-industries-inc-an…
Antwort auf Beitrag Nr.: 59.315.147 von Grosstolany am 28.11.18 10:48:39
Moin,
die Zahlen!!!
November 28, 2018
1933 Industries Inc. Announces Fourth Quarter and Year End Financial Results
1933 Industries Inc. is pleased to announce financials for the fourth quarter and the year ending July 31st, 2018. All amounts expressed are in Canadian dollars unless stated otherwise.
Fiscal 2018 Highlights
Record sales revenues of $12,649,926 for the year
Overall gross margins for 2018 of 49%
Total assets increased to $41,339,616
Product offering expanded to over 120 SKU’s available in over 500 Stores
“We are very pleased with the results of our first full year of operations as a public entity and we have experienced substantial growth through our operating subsidiaries. 1933 has invested significant capital in building out our new cultivation and production facilities in Las Vegas, which will be operational in the new year,” stated Mr. Brayden Sutton, President and CEO of the Company. He added, “The Company is actively expanding its footprint in Nevada, California, Colorado and is currently evaluating opportunities in other legal jurisdictions.”
Selected Annual Information
The Company recorded annual revenue of $8,214,915 and $4,335,768 generated from AMA and Infused respectively. Net loss for the year ended July 31, 2018 was $5,729,052. The Company’s loss was primarily driven by investment in future growth initiatives.
Alternative Medicine Association (“AMA” - 91% ownership)
AMA contributed 65% to the Company’s total revenue
AMA generated an overall gross margin of 37% ($3,272,703)
The positive contributing income before tax from AMA is $1,353,485
Infused Manufacturing (“Infused” - 91% ownership)
Infused contributed 34% of the Company’s total revenue
Infused generated an overall gross margin of 71% ($3,078,763)
Infused broke even in its first full year of operations
Consolidated Results
2018 2017 2016
Total revenue $ 12,649,926 $ 1,030,297 $
Gross profit 6,450,709 230,714
Net loss (5,729,052) (2,740,657) (3,674,780)
Comprehensive loss (4,791,300) (3,793,029) (3,674,780)
Basic and diluted loss per share (0.02) (0.06) (0.10)
2018 2017 2016
Current assets $ 13,398,978 $ 1,971,873 $ 24,693
Total assets 41,339,616 18,897,362 413,693
Current liabilities 2,391,088 2,890,483 707,568
Total liabilities 4,356,119 2,890,483 707,568
2018 Fourth Quarter Highlights
For the three-month period ending July 31, 2018, the Company reports revenue of $3,905,243 from the sale of medical and adult-use cannabis and hemp/CBD infused products, an 18% increase from $3,317,497 during the previous quarter.
Selected Quarterly Information
Q4 Q3
Revenue $ 3,905,243 $ 3,317,497
Gross Profit $ 2,012,812 $ 1,463,550
Non-Current Assets $ 28,536,283 $ 24,494,836
Cash at end of period $ 9,649,422 $ 13,098,874
Total Liabilities $ 4,356,119 $ 3,646,252
In Q4, Infused reports $1,546,508 in sales revenues, an increase of 30% from $1,192,051 in Q3 from its hemp-based, CBD-infused wellness product lines.
Alternative Medicine Association reports $2,282,485 in sales revenue in Q4, up 9% from $2,102,453 in Q3, driven by strong sales of cannabis flower and concentrates.
The Company’s advisory arm, Spire Global Strategy reported consulting revenue of $84,993 for the fourth quarter.
Developments in Q4
1933 Industries achieved steady growth during its fourth quarter and completed significant corporate developments, including:
On May 5, 2018, the Company and its subsidiary, AMA, announced that they had entered into a purchase agreement for an existing 12,160 sq. ft. building adjacent to the future cultivation facility.
On May 28, 2018, the Company and its subsidiary, Infused, announced a one-year licensing agreement with professional poker player, Mr. Scotty Nguyen.
On June 5, 2018, the Company and its subsidiary, Infused announced a one-year licensing agreement with Denver Dab Company (DDC") to produce the Company's line of products in the state of Colorado.
On June 6, 2018, the Company announced the closing of the previously announced purchase agreement dated May 15th, 2018 on the production building in Las Vegas, Nevada, which will house a separate hemp processing facility (the CBD Lab) operated by its subsidiary, Infused.
On July 24, the Company announced that Infused had secured an Industrial Hemp Handler Conditional Certificate from the Nevada Department of Agriculture (NDA) Industrial Hemp program, for its proposed hemp processing facility in Las Vegas, Nevada.
Subsequent Developments:
On August 3, the Company announced the filing of a preliminary short form prospectus with a commercially reasonable efforts offering of convertible debenture units for aggregate gross proceeds of up to $15,000,000, led by Canaccord Genuity Corp. as lead agent and sole book-runner, together with Beacon Securities Limited.
On August 7, the Company announced record sales for the month of July from its subsidiaries in Nevada and reported combined sales of $1.6M CAD, a 362 percent increase over July 2017.
On August 31, the Company announced the receipt for its final short form prospectus filed with the securities regulatory authorities in British Columbia, Alberta, Saskatchewan and Ontario, in connection with the previously-announced offering of convertible debenture units of the Company.
On September 14, the Company announced the closing of its short form prospectus offering of convertible debenture units, which included the exercise of an overallotment option, and raised gross proceeds of $17,250,000.
On September 27, the Company announced the continuation out of the province of Alberta and into the province of B.C. and concurrent name change to 1933 Industries Inc.
Detailed information on the financials and the management's discussion and analysis can be found at https://sedar.com/
Moin,
die Zahlen!!!
November 28, 2018
1933 Industries Inc. Announces Fourth Quarter and Year End Financial Results
1933 Industries Inc. is pleased to announce financials for the fourth quarter and the year ending July 31st, 2018. All amounts expressed are in Canadian dollars unless stated otherwise.
Fiscal 2018 Highlights
Record sales revenues of $12,649,926 for the year
Overall gross margins for 2018 of 49%
Total assets increased to $41,339,616
Product offering expanded to over 120 SKU’s available in over 500 Stores
“We are very pleased with the results of our first full year of operations as a public entity and we have experienced substantial growth through our operating subsidiaries. 1933 has invested significant capital in building out our new cultivation and production facilities in Las Vegas, which will be operational in the new year,” stated Mr. Brayden Sutton, President and CEO of the Company. He added, “The Company is actively expanding its footprint in Nevada, California, Colorado and is currently evaluating opportunities in other legal jurisdictions.”
Selected Annual Information
The Company recorded annual revenue of $8,214,915 and $4,335,768 generated from AMA and Infused respectively. Net loss for the year ended July 31, 2018 was $5,729,052. The Company’s loss was primarily driven by investment in future growth initiatives.
Alternative Medicine Association (“AMA” - 91% ownership)
AMA contributed 65% to the Company’s total revenue
AMA generated an overall gross margin of 37% ($3,272,703)
The positive contributing income before tax from AMA is $1,353,485
Infused Manufacturing (“Infused” - 91% ownership)
Infused contributed 34% of the Company’s total revenue
Infused generated an overall gross margin of 71% ($3,078,763)
Infused broke even in its first full year of operations
Consolidated Results
2018 2017 2016
Total revenue $ 12,649,926 $ 1,030,297 $
Gross profit 6,450,709 230,714
Net loss (5,729,052) (2,740,657) (3,674,780)
Comprehensive loss (4,791,300) (3,793,029) (3,674,780)
Basic and diluted loss per share (0.02) (0.06) (0.10)
2018 2017 2016
Current assets $ 13,398,978 $ 1,971,873 $ 24,693
Total assets 41,339,616 18,897,362 413,693
Current liabilities 2,391,088 2,890,483 707,568
Total liabilities 4,356,119 2,890,483 707,568
2018 Fourth Quarter Highlights
For the three-month period ending July 31, 2018, the Company reports revenue of $3,905,243 from the sale of medical and adult-use cannabis and hemp/CBD infused products, an 18% increase from $3,317,497 during the previous quarter.
Selected Quarterly Information
Q4 Q3
Revenue $ 3,905,243 $ 3,317,497
Gross Profit $ 2,012,812 $ 1,463,550
Non-Current Assets $ 28,536,283 $ 24,494,836
Cash at end of period $ 9,649,422 $ 13,098,874
Total Liabilities $ 4,356,119 $ 3,646,252
In Q4, Infused reports $1,546,508 in sales revenues, an increase of 30% from $1,192,051 in Q3 from its hemp-based, CBD-infused wellness product lines.
Alternative Medicine Association reports $2,282,485 in sales revenue in Q4, up 9% from $2,102,453 in Q3, driven by strong sales of cannabis flower and concentrates.
The Company’s advisory arm, Spire Global Strategy reported consulting revenue of $84,993 for the fourth quarter.
Developments in Q4
1933 Industries achieved steady growth during its fourth quarter and completed significant corporate developments, including:
On May 5, 2018, the Company and its subsidiary, AMA, announced that they had entered into a purchase agreement for an existing 12,160 sq. ft. building adjacent to the future cultivation facility.
On May 28, 2018, the Company and its subsidiary, Infused, announced a one-year licensing agreement with professional poker player, Mr. Scotty Nguyen.
On June 5, 2018, the Company and its subsidiary, Infused announced a one-year licensing agreement with Denver Dab Company (DDC") to produce the Company's line of products in the state of Colorado.
On June 6, 2018, the Company announced the closing of the previously announced purchase agreement dated May 15th, 2018 on the production building in Las Vegas, Nevada, which will house a separate hemp processing facility (the CBD Lab) operated by its subsidiary, Infused.
On July 24, the Company announced that Infused had secured an Industrial Hemp Handler Conditional Certificate from the Nevada Department of Agriculture (NDA) Industrial Hemp program, for its proposed hemp processing facility in Las Vegas, Nevada.
Subsequent Developments:
On August 3, the Company announced the filing of a preliminary short form prospectus with a commercially reasonable efforts offering of convertible debenture units for aggregate gross proceeds of up to $15,000,000, led by Canaccord Genuity Corp. as lead agent and sole book-runner, together with Beacon Securities Limited.
On August 7, the Company announced record sales for the month of July from its subsidiaries in Nevada and reported combined sales of $1.6M CAD, a 362 percent increase over July 2017.
On August 31, the Company announced the receipt for its final short form prospectus filed with the securities regulatory authorities in British Columbia, Alberta, Saskatchewan and Ontario, in connection with the previously-announced offering of convertible debenture units of the Company.
On September 14, the Company announced the closing of its short form prospectus offering of convertible debenture units, which included the exercise of an overallotment option, and raised gross proceeds of $17,250,000.
On September 27, the Company announced the continuation out of the province of Alberta and into the province of B.C. and concurrent name change to 1933 Industries Inc.
Detailed information on the financials and the management's discussion and analysis can be found at https://sedar.com/
Antwort auf Beitrag Nr.: 59.283.634 von ThatstheWayItGoes am 23.11.18 10:46:50So ! Heute wird es wieder spannend! Quartalszahlen stehen an! Vielleicht gibt es ja auch ne kleine Überraschung ?? Lg ! 2019 wird aber deutlich interessanter werden mit der neuen Anlage und dem CBD Gebäude!
Trading Spotlight
Antwort auf Beitrag Nr.: 59.280.136 von grassfalter am 22.11.18 18:57:41Absolut TOP 
neues Video TOP
https://www.b-tv.com/1933-industries-company-feature-ep-333/
Antwort auf Beitrag Nr.: 59.271.061 von grassfalter am 21.11.18 18:53:21Ja die Sache mit Italien dazu die Brexit Angelegenheit und Trump bzgl. China und Zölle belasten den Markt sehr. Nicht einfach. Kann böse enden.
Richte mich mal stark nach Dow bzw. S&P 500.
Hoffe mal das geht gut aus und es ist kein crash auf Raten das wäre der worst case.
Richte mich mal stark nach Dow bzw. S&P 500.
Hoffe mal das geht gut aus und es ist kein crash auf Raten das wäre der worst case.
Antwort auf Beitrag Nr.: 59.271.007 von Nichtottonormal am 21.11.18 18:47:14Q4 4,4 mio
Ja echt anstrengend der markt seit zwei Wochen.....
Ja echt anstrengend der markt seit zwei Wochen.....
Antwort auf Beitrag Nr.: 59.261.830 von grassfalter am 20.11.18 19:11:51Ich bin bei 4,1 Mio CAD Q4.
Schau dir den Markt momentan an.
Ich hoffe auf Erholung.
Schau dir den Markt momentan an.
Ich hoffe auf Erholung.
Durchsuchen
